Locate Bio’s LDGraft Granted FDA Breakthrough Device Designation

18th May, 2023

Locate Bio Closes £10 million Funding Round

3rd September, 2021

Locate Bio’s Chondro3 Granted FDA Breakthrough Device Designation

24th February, 2021

CognitOss Granted FDA Breakthrough Device Designation

7th January, 2021

Locate Bio appoints Keith Valentine as the Non-Executive Chair of the Board of Directors

5th January, 2021

Locate Bio acquires complementary late stage orthobiologics assets

21st September, 2020

Locate Bio raises £2.25m for new spinal treatments

20th July, 2020

Locate Bio announces the appointment of John von Benecke as CEO

14th May, 2020

Locate Bio receives £2.0 million investment from Mercia and the MEIF to expand its cell and gene therapy pipeline

15th May, 2019

Locate Therapeutics announces name change to Locate Bio and new investment from Mercia Technologies PLC

16th October, 2018